Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Waters and Spark Holland Enter Co-marketing Agreement for High Volume Labs

By HospiMedica staff writers
Posted on 05 Mar 2007
Waters Corporation (Milford, MA, USA) and Spark Holland (Emmen, The Netherlands), have entered into a co-marketing agreement to promote an integrated solution for high volume clinical laboratories. More...
These integrated systems are comprised of Waters' mass spectrometers and Spark Holland's symbiosis on-line solid phase extraction (SPE) system under the control of Waters MassLynx mass spectrometry data acquisition, processing, and reporting software.

With this integrated system high-volume labs can now automate sample processing, analysis, and data reduction. This will enable high volume clinical and forensic laboratories worldwide to analyze samples faster, increase throughput, and lower costs.

We are pleased to enter into this co-marketing agreement with Spark Holland. We believe that the combination of on-line SPE using Waters Oasis sorbents together with our mass spectrometers is truly enabling for customers in high-throughput environments for automating and integrating sample preparation, separation, and detection, said Michael Yelle, senior director of clinical operations at Waters corporation.

"We believe that the power of the Waters mass spectrometers combined with the Symbiosis front-end automation--all controlled from a single software package--is a big step towards a fully integrated analyzer for the clinical market. Better workflow with less manual handling should improve throughput and quality of the analysis. We are excited about our co-marketing arrangement with Waters and believe it can deliver great benefits for our joint customers,” said Rob Castien, president of Spark Holland.

Waters Clinical Business Operations group is dedicated to the adoption of liquid chromatography/mass spectrometry (LC/MS) in the clinical market worldwide. Waters customers are supported by a scientific team in the United Kingdom and dedicated clinical support staff in the United States and Europe.

Spark pioneered solid phase extraction with on-line elution into high performance liquid chromatography (HPLC) and LC-MS systems in the 1980s, followed by its introduction to the market in the early 1990s. Since, the company has evolved to a world-class provider of innovative sample introduction, extraction, and separation technology for analytical systems such as HPLC, MS, gas chromatography (GC), and nuclear magnetic resonance (NMR).

Waters Corporation holds worldwide leading positions in three complementary analytical technologies--liquid chromatography, mass spectrometry, and thermal analysis.


Related Links:
Waters Corporation
Spark Holland

Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical Examination & Procedure Light
Vega 80
Immobilization System
Cranial 4Pi Immobilization
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image Credit: Adobe Stock

Noninvasive Imaging Approach Aims to Detect Basal Cell Carcinoma Before It Becomes Visible

Basal cell carcinoma is the most common form of skin cancer and can damage nearby structures such as the nose or eyes when it develops on the face. Diagnosis typically depends on visible skin changes,... Read more

Surgical Techniques

view channel
Image: Associate Professor Menglin Chen studies how the light-sensitive nanoparticles affect living cells. The screen shows calcium being released inside a cell after nanoparticles taken up by the cell are exposed to blue light. Calcium plays an important role in cellular signaling, and the experiment helps the researchers understand how the nanoparticles can translate light into biological activity. (Photo courtesy of Aarhus University, Johanne Holm Jensen)

Light-Activated Nanoparticles May Offer New Approach to Retinal Prostheses

Retinitis pigmentosa is a degenerative retinal disorder in which photoreceptors progressively die, reducing visual signals to the brain while leaving surviving inner retinal circuits underused.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.